ArticlePharmaceuticals (Basel, Switzerland)2018

Design, Synthesis, In Vitro, and Initial In Vivo Evaluation of Heterobivalent Peptidic Ligands Targeting Both NPY(Y₁)- and GRP-Receptors-An Improvement for Breast Cancer Imaging?

Alicia Vall-Sagarra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.